Mary K. Pendergast

Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland.

ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO.

AesRx LLC is a biopharmaceutical company. The firm develops pharmaceutical products for the treatments for two orphan diseases. It offers Aes-103, a is targeted to the treatment of sickle cell disease. The company was founded by Stephen Seiler on November 22, 2010 and is headquartered in Newton, MA.

US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD.

G2B Pharma, Inc. focuses on the development of nasally delivered drugs, including nasally delivered epinephrine for the treatment of anaphylaxis. Its product anaphylaxis, a severe and life-threatening allergic reaction that can include rash, swelling of the tongue and throat, and a sudden drop in blood pressure. The company was founded by Nigel Ten Fleming and Mike Doodson and is headquartered in Corte Madera, CA.